dr. reckamp discusses the use of hsp90 inhibitors
Published 13 years ago • 562 plays • Length 0:32Download video MP4
Download video MP3
Similar videos
-
0:41
dr. reckamp describes the use of heat shock proteins
-
1:10
dr. reckamp discusses heat shock proteins in lung cancer
-
1:31
dr. bendell on hsp90 inhibition in advanced solid tumors
-
0:37
dr. reckamp on current heat shock protein clinical trials
-
1:02
dr. reckamp on mk-2206 for the treatment of egfr wild-type nsclc
-
2:14
the science of heat shock proteins in proteostasis
-
1:01:18
beyond vaccines: the role of repurposed therapeutics in preventing covid-19 deaths
-
10:41
doffing personal protective equipment (ppe) for high consequence infectious diseases (hcids)
-
1:06
dr. suresh ramalingam on hsp90 inhibition with ganetespib in lung cancer
-
4:56
galaxy-1 trial: investigation of hsp90 inhibitors in nsclc
-
8:55
cdk4/6 inhibitors in hr metastatic breast cancer
-
1:43
dr. herzog on the use of hipec in ovarian cancer
-
3:44
questioning cdk4/6 inhibitor cross-resistance in hr mbc
-
13:05
expert perspectives: cdk 4/6 inhibitor therapy for er metastatic breast cancer
-
5:31
efficacy of cdk4/6 inhibitors in hr mbc
-
10:19
quality of life for women with hr-positive breast cancer
-
2:01
dr. finn on the revolution of cdk4/6 inhibition in hr breast cancer
-
1:00
hss minute: hip preservation
-
3:00
what is hrp? craig lissner: hrp@50 expert series
-
1:23
dr. suresh ramalingam explores cytotoxics in lung cancer
-
1:12
dr. fuqua on esr1 mutations in primary breast cancer
-
1:05
dr. west discusses crizotinib in alk-nsclc trial results